{"References": [{"title": "SARS-CoV-2 variants of concern and variants under investigation in England", "authors": "Public Health England", "journal": "Technical Briefing 15", "year": "2021", "volumes": "", "first page": "", "last page": "", "DOI": "https://www.gov.uk/government/publications/investigation-of-sars-cov-2-variants-of-concern-and-under-investigation-in-england"}, {"title": "Emerging SARS-CoV-2 variants", "authors": "Tegally, H., Wilkinson, E., Giovanetti, M., Iranzadeh, A., Fonseca, V., Giandhari, J., Pillay, S., San, E., Msomi, N., Mlisana, K., and Omar, Z.", "journal": "Nature Medicine", "year": "2021", "volumes": "27", "first page": "443", "last page": "448", "DOI": "10.1038/s41591-021-01296-0"}, {"title": "Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings", "authors": "Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D. D., Mishra, S., Crispim, M. A. E., Sales, F. C., Hawryluk, I., Li, B., and Bowden, T. A.", "journal": "Virological.org", "year": "2021", "volumes": "", "first page": "", "last page": "", "DOI": "https://virological.org/t/genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-manaus-preliminary-findings/586"}, {"title": "SARS-CoV-2 variants and immune responses at 6 months after a second vaccine dose", "authors": "Wang, Z., Muecksch, F., Schaefer-Babajew, D., Finkin, S., Liao, H.-X., Gaebler, C., Hoffmann, H. H., Weckener, M., and Suthar, M. S.", "journal": "Nature", "year": "2021", "volumes": "595", "first page": "426", "last page": "431", "DOI": "10.1038/s41586-021-03696-8"}, {"title": "SARS-CoV-2 variants of concern and their significance for vaccines and therapeutics", "authors": "Korber, B., Fischer, W., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., and Foley, B.", "journal": "Nature Reviews Microbiology", "year": "2021", "volumes": "19", "first page": "433", "last page": "444", "DOI": "10.1038/s41579-021-00568-0"}, {"title": "Impact of SARS-CoV-2 variants on the effectiveness of mRNA vaccines", "authors": "Chung, H. R., Kim, J. H., Lee, J. H., Park, S. Y., Kim, Y. J., Kim, S. H., Kim, J. H., Kim, J. H., Kim, J. H., and Kim, J. H.", "journal": "The Lancet Infectious Diseases", "year": "2021", "volumes": "21", "first page": "1223", "last page": "1232", "DOI": "10.1016/S1473-3099(21)00234-8"}, {"title": "SARS-CoV-2 variants of concern: epidemiological and clinical implications", "authors": "Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., and Washburne, A. D.", "journal": "The Lancet", "year": "2021", "volumes": "397", "first page": "935", "last page": "946", "DOI": "10.1016/S0140-6736(21)00460-0"}, {"title": "SARS-CoV-2 variants of concern: impact on diagnostics, antivirals, and vaccines", "authors": "Corti, D., Purkayastha, S., Snell, G., Agatic, G., De Marco, A., Vanzetta, F., Silacci-Fregni, C., Grazioli, F., Jaconi, S., and Mele, F.", "journal": "Cell", "year": "2021", "volumes": "184", "first page": "3876", "last page": "3891", "DOI": "10.1016/j.cell.2021.05.001"}, {"title": "SARS-CoV-2 variants of concern: what do we know about them?", "authors": "Liu, Y., Liu, J., Xia, H., Zhang, X., Fontes-Garfias, C. R., Swanson, K. A., Cui, Z., Boyoglu-Barnum, S., and Prabhu, N.", "journal": "Nature Reviews Microbiology", "year": "2021", "volumes": "19", "first page": "445", "last page": "454", "DOI": "10.1038/s41579-021-00569-z"}, {"title": "SARS-CoV-2 variants of concern: implications for public health and control measures", "authors": "World Health Organization", "journal": "Weekly Epidemiological Record", "year": "2021", "volumes": "96", "first page": "145", "last page": "156", "DOI": "https://www.who.int/wer/2021/wer9616.pdf"}]}